Puma Biotechnology Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Puma Biotech (PBYI) Tops Q1 EPS by 89c
May 9, 2019 5:13 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q1 EPS of $0.21, $0.89 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $99.1 million versus the consensus estimate of $67.25 million.
For earnings history and earnings-related data on Puma Biotech (PBYI) click here.
... More